The MoU was signed today by MTPConnect CEO Sue MacLeman and LSQ CEO Mario Pennisi at the Brisbane Convention and Exhibition Centre.
03 May 2017
Interested parties encouraged to start preparing their applications to share in the $8.2 million of available funding.
Expressions of interest are now open to take part in The Bridge Program - face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that contribute to research translation and the commercialisation of medicines.
MTPConnect today launched the final Sector Competitiveness Plan (SCP), a 10-year strategic plan to maximise the innovation, productivity and competitiveness of Australia's MTP sector.
MTPConnect and the Advanced Manufacturing Growth Centre (AMGC) have signed a memorandum of understanding (MoU) to work together in undertaking activities to accelerate the growth of advanced manufacturing in the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.
MTPConnect welcomes the launch of the Australian Government's $500 million Biomedical Translation Fund (BTF) and announcement of three established and qualified venture capital fund managers set to roll out the investment.
MTPConnect and AusBiotech have signed a memorandum of understanding (MoU) to work together in undertaking activities to accelerate the growth of the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.
MTPConnect today announced it will provide $7.4 million of funding over two years for 14 national projects in the medtech, biotech and pharmaceutical (MTP) sector.
Ms Sue MacLeman, Managing Director and CEO MTPConnect will present on Australia's medtech capabilities and competitive advantages at a medtech Showcase in Seoul.
MTPConnect is delighted to announce the appointment of three General Managers.
Wednesday, 10 August 2016, Canberra, Australia--MTPConnect and ARCS Australia have signed a Memorandum of Understanding (MoU), agreeing to work closely together for the benefit of the MedTech, biotechnology and pharmaceutical industry.
MTPConnect unveils 10-year plan to boost competitiveness of medtech, biotech and pharmaceutical sector
Australia--Monday 25th July, 2016: MTPConnect--The Medical Technologies and Pharmaceuticals Industry Growth Centre--today launched its Draft Sector Competitiveness Plan (Draft SCP), a 10-year strategic plan to boost the innovation, productivity and competitiveness of Australia's medical technology, biotechnology, and pharmaceutical (MTP) sector.